← Back to home

PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS

Clinical trials for PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS explained in plain language.

Never miss a new study

Get alerted when new PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS trials appear

Sign up with your email to follow new studies for PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Early trial tests 'Universal' cell injection for tough kidney diseases

Disease control Recruiting now

This early-stage study is testing a new cell therapy called GT719 in adults with several types of immune-mediated kidney diseases that have not responded well to standard treatments. The main goals are to find a safe dose and see how well the body tolerates the treatment, while a…

Matched conditions: PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS

Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS

Get alerted when new PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN DEPOSITS trials appear

Early trial tests 'Universal' cell injection for tough kidney diseases